Folic acid supplementation doesn't boost cancer risk, analysis finds

01/28/2013 | Reuters

An examination of 13 trials involving nearly 50,000 individuals found no significant difference in the incidence of cancer between those who received folic acid supplements for five years and those who took placebos. Folic acid was not associated with a greater likelihood of developing certain types of cancer, either, including cancers of the colon, prostate, lung or breast.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX